T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
American Water Works
AWK
$27.1B
| $230M | 0.04% |
1,921,421
-4,454,557
| -70% | -$575M |
|
377
Sun Life Financial
SLF
$44.7B
| $228M | 0.04% |
7,183,658
+227,587
| +3% | +$9.75M |
|
378
Dentsply Sirona
XRAY
$2.29B
| $226M | 0.04% |
5,812,663
+468,109
| +9% | +$23.9M |
|
379
Occidental Petroleum
OXY
$57.6B
| $226M | 0.04% |
19,487,701
-13,448,362
| -41% | -$442M |
|
380
Monster Beverage
MNST
$91.3B
| $225M | 0.04% |
15,973,560
+2,619,544
| +20% | +$42.1M |
|
381
FIVE9
FIVN
$2.52B
| $224M | 0.04% |
2,935,101
+1,250,283
| +74% | +$89.1M |
|
|
AJRD
382
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $224M | 0.04% |
5,357,220
-1,070,198
| -17% | -$52.6M |
|
383
Sea Limited
SE
$76.1B
| $224M | 0.04% |
5,052,503
+1,864,814
| +59% | +$83.6M |
|
384
Canadian Pacific Kansas City
CP
$82.6B
| $222M | 0.04% |
5,053,480
-2,517,230
| -33% | -$124M |
|
385
Gen Digital
GEN
$17.6B
| $220M | 0.03% |
11,741,310
-8,405,185
| -42% | -$182M |
|
386
Fidelity National Financial
FNF
$13.1B
| $219M | 0.03% |
9,139,447
-8,957,735
| -49% | -$352M |
|
387
Enbridge
ENB
$112B
| $218M | 0.03% |
7,509,297
+6,400,437
| +577% | +$237M |
|
388
Baidu
BIDU
$35.5B
| $218M | 0.03% |
2,161,690
-294,137
| -12% | -$35.8M |
|
389
Kodiak Sciences
KOD
$2.55B
| $217M | 0.03% |
4,554,088
+477,861
| +12% | +$28.7M |
|
390
C.H. Robinson
CHRW
$17.6B
| $216M | 0.03% |
3,265,899
+75,309
| +2% | +$5.41M |
|
391
Lattice Semiconductor
LSCC
$18.3B
| $216M | 0.03% |
12,111,770
-188,606
| -2% | -$3.57M |
|
392
United Airlines
UAL
$41B
| $216M | 0.03% |
6,838,426
-5,676,605
| -45% | -$375M |
|
393
Newmont
NEM
$120B
| $214M | 0.03% |
4,722,329
-777,958
| -14% | -$35.1M |
|
|
PDCO
394
DELISTED
Patterson Companies, Inc.
PDCO
| $214M | 0.03% |
13,975,498
+1,130,099
| +9% | +$24.4M |
|
395
Western Alliance Bancorporation
WAL
$8.95B
| $213M | 0.03% |
6,959,012
-109,653
| -2% | -$5.24M |
|
396
ESCO Technologies
ESE
$7.73B
| $211M | 0.03% |
2,781,255
-16,198
| -0.6% | -$1.48M |
|
|
BPMC
397
DELISTED
Blueprint Medicines
BPMC
| $210M | 0.03% |
3,586,091
+232,524
| +7% | +$15M |
|
398
Ultragenyx Pharmaceutical
RARE
$2.62B
| $209M | 0.03% |
4,708,822
+217,053
| +5% | +$11.3M |
|
399
Emerson Electric
EMR
$91.2B
| $206M | 0.03% |
4,318,208
+457,598
| +12% | +$30.1M |
|
400
Caterpillar
CAT
$392B
| $205M | 0.03% |
1,763,760
-1,637,336
| -48% | -$209M |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.